Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
  • Power of Women 2024
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Youth Summit
    • Critical Thinking Forum
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Digital Editions
    • Crossword
    • WhatsApp Channel
    • Register
    • Login
    • Lost Password

           

antiretroviral

What researchers learnt from five baby boys in KwaZulu-Natal about an HIV cure
Health
/ 10 December 2024

What researchers learnt from five baby boys in KwaZulu-Natal about an HIV cure

A groundbreaking study published in Nature Medicine gives insight into what an HIV cure could look like during infancy

By Tian Johnson
Protect everyone’s rights to protect everyone’s health against Aids
Opinion
/ 1 March 2024

Protect everyone’s rights to protect everyone’s health against Aids

Zero discrimination is essential to if we are to change the fact that 7.8 million South Africans live with HIV, but 5.8 million people are on ARVs, highlighting a treatment gap

By Eva Kiwango
World leaders can choose the path that ends Aids
Thought Leader
/ 8 September 2023

World leaders can choose the path that ends Aids

World leaders can choose the path that ends Aids

By Winnie Byanyima
How a change in ARV distribution could help treat more people with HIV
Health
/ 23 August 2023

How a change in ARV distribution could help treat more people with HIV

Private pharmacies to join the management of antiretroviral treatment programme, making it easier for those who need the life-long medicine

By Lilly Roberts and Linda Pretorius
Four ways to make it easy to take the HIV prevention pill
Health
/ 2 December 2022

Four ways to make it easy to take the HIV prevention pill

The Aurum Institute is making it easier for people to get HIV prevention medication

By Maria Sibanyoni, Jacqueline Pienaar, Vuyolwethu Ncube and Matshidiso Chabane
Policy changes around HIV lead to drop in breastfeeding
Health
/ 8 April 2022

Policy changes around HIV lead to drop in breastfeeding

A new study suggests that changes in policies have led to decreased breastfeeding

By Munyaradzi Makoni
Letter to UNAids: End Aids deaths by 2030
Opinion
/ 8 February 2022

Letter to UNAids: End Aids deaths by 2030

Setting new 90-90-90 targets for CD4 testing, cryptococcal antigen, and TB testing, and treatment, aligned to the WHO AHD package of care would be a positive step towards ending Aids deaths by 2030

By Open Letter

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2024 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}